atenolol has been researched along with Substance Withdrawal Syndrome in 28 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of the withdrawal of long-term beta-adrenoceptor blockade on pulse rate and finger tremor was studied in 27 patients who had been treated for 2 years following an uncomplicated myocardial infarction with either atenolol, propranolol or placebo." | 9.05 | Effect on finger tremor of withdrawal of long-term treatment with propranolol or atenolol. ( Birmingham, AT; Roland, JM; Wharrad, HJ; Williams, EJ; Wilson, CG, 1984) |
| "The effect of the withdrawal of long-term beta-adrenoceptor blockade on pulse rate and finger tremor was studied in 27 patients who had been treated for 2 years following an uncomplicated myocardial infarction with either atenolol, propranolol or placebo." | 5.05 | Effect on finger tremor of withdrawal of long-term treatment with propranolol or atenolol. ( Birmingham, AT; Roland, JM; Wharrad, HJ; Williams, EJ; Wilson, CG, 1984) |
| "The effects of abrupt withdrawal of atenolol, a long acting cardioselective beta blocker, were studied in 20 patients with severe stable angina pectoris admitted to hospital for coronary arteriography." | 3.67 | Abrupt withdrawal of atenolol in patients with severe angina. Comparison with the effects of treatment. ( Barritt, DW; Bauminger, B; Farr, S; Marshall, AJ; Walker, PR; Walters, G, 1985) |
| "Abrupt withdrawal of the centrally-acting antihypertensive agent, clonidine, is associated with a high incidence of rebound hypertension and tachycardia, with symptoms of sympathetic overactivity and increased catecholamine excretion." | 3.67 | Regimen for the control of blood pressure and symptoms during clonidine withdrawal. ( Campbell, BC; Reid, JL, 1985) |
| "Effect of morphine dependence and its withdrawal on the 3H-dihydroalprenolol (3H-DHA) binding for beta -adrenergic receptors, beta 1 and beta 2, was examined by a computerized analysis of biphasic Hofstee plots." | 3.66 | Differential effects of morphine withdrawal on cerebral beta 1- and beta 2-adrenergic receptors. ( Kuriyama, K; Muramatsu, M; Ohkuma, S; Ping, ZP; Tamura, J, 1981) |
| "Among patients who had withdrawal symptoms at baseline, vital signs became normal more rapidly in the patients receiving atenolol, and their abnormal behavioral characteristics also resolved more rapidly." | 2.66 | The efficacy of atenolol in the outpatient management of the alcohol withdrawal syndrome. Results of a randomized clinical trial. ( Gottlieb, LD; Horwitz, RI; Kraus, ML, 1989) |
| "Among patients who had withdrawal symptoms at base line, vital signs became normal more rapidly in the patients receiving atenolol, and their abnormal behavior and clinical characteristics also resolved more rapidly." | 2.66 | Randomized clinical trial of atenolol in patients with alcohol withdrawal. ( Anscher, M; Gottlieb, LD; Horwitz, RI; Kraus, ML, 1985) |
| "Among patients who had withdrawal symptoms at baseline, vital signs became normal more rapidly in the patients receiving atenolol; abnormal behavior and clinical characteristics also resolved more rapidly." | 2.66 | The role of beta blockers in alcohol withdrawal syndrome. ( Gottlieb, LD, 1988) |
| " 3 No significant differences in the pharmacokinetic profile of atenolol were evident between the values obtained following chronic dosing and an acute single-dose study." | 1.26 | Withdrawal of long-term therapy with atenolol in hypertensive patients. ( Barber, HE; Hawksworth, GM; Jeffers, TA; Petrie, JC; Webster, J, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (67.86) | 18.7374 |
| 1990's | 8 (28.57) | 18.2507 |
| 2000's | 1 (3.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishiyama, T | 1 |
| Oguchi, T | 1 |
| Yamaguchi, T | 1 |
| Kumazawa, T | 1 |
| Henderson, A | 1 |
| Sheridan, D | 1 |
| Ross, J | 1 |
| Lewis, M | 1 |
| Walden, RJ | 3 |
| Hernandez, J | 1 |
| Yu, Y | 1 |
| Al-Khader, A | 1 |
| Prichard, BN | 3 |
| Lilja, M | 1 |
| Jounela, AJ | 1 |
| Juustila, HJ | 1 |
| Paalzow, L | 1 |
| Kuriyama, K | 1 |
| Muramatsu, M | 1 |
| Ohkuma, S | 1 |
| Tamura, J | 1 |
| Ping, ZP | 1 |
| Wharrad, HJ | 1 |
| Birmingham, AT | 1 |
| Wilson, CG | 1 |
| Williams, EJ | 1 |
| Roland, JM | 1 |
| Hausen, T | 1 |
| Schwartz, J | 1 |
| Jackson, G | 1 |
| Kates, RE | 1 |
| Harrison, DC | 1 |
| Webster, J | 1 |
| Hawksworth, GM | 1 |
| Barber, HE | 1 |
| Jeffers, TA | 1 |
| Petrie, JC | 1 |
| Funada, M | 1 |
| Suzuki, T | 1 |
| Sugano, Y | 1 |
| Tsubai, M | 1 |
| Misawa, M | 1 |
| Ueda, H | 1 |
| Misu, Y | 1 |
| Harris, GC | 2 |
| Aston-Jones, G | 2 |
| Deckert, J | 1 |
| Przuntek, H | 1 |
| Gleiter, CH | 1 |
| Kristensen, BO | 1 |
| Neff, DA | 1 |
| McQueen, KD | 1 |
| Gilligan, DM | 1 |
| Chan, WL | 1 |
| Stewart, R | 1 |
| Oakley, CM | 1 |
| Tomlinson, B | 2 |
| Graham, B | 2 |
| Smith, C | 1 |
| Betteridge, DJ | 1 |
| Liu, JB | 1 |
| Horwitz, RI | 2 |
| Gottlieb, LD | 3 |
| Kraus, ML | 2 |
| Slagle, DA | 1 |
| Anscher, M | 1 |
| Lewis, MJ | 1 |
| Henderson, AH | 1 |
| Ashford, A | 1 |
| Walker, PR | 1 |
| Marshall, AJ | 1 |
| Farr, S | 1 |
| Bauminger, B | 1 |
| Walters, G | 1 |
| Barritt, DW | 1 |
| Lerner, WD | 1 |
| Fallon, HJ | 1 |
| Campbell, BC | 1 |
| Reid, JL | 1 |
1 review available for atenolol and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Beta-blockers in alcohol withdrawal.
Topics: Adrenergic beta-Antagonists; Atenolol; Benzodiazepines; Double-Blind Method; Ethanol; Humans; Substa | 1991 |
8 trials available for atenolol and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Effect on finger tremor of withdrawal of long-term treatment with propranolol or atenolol.
Topics: Atenolol; Blood Pressure; Female; Fingers; Humans; Male; Middle Aged; Physical Exertion; Posture; Pr | 1984 |
Beta-blockers in alcohol withdrawal.
Topics: Adrenergic beta-Antagonists; Atenolol; Benzodiazepines; Double-Blind Method; Ethanol; Humans; Substa | 1991 |
Withdrawal phenomena after atenolol and bopindolol: hormonal changes in normal volunteers.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Glucose; Catecholamines; Female; Hormones; Humans; Hydr | 1990 |
Withdrawal phenomena after atenolol and bopindolol: haemodynamic responses in healthy volunteers.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Exercise Test; Female; Heart Rate; Hor | 1990 |
The efficacy of atenolol in the outpatient management of the alcohol withdrawal syndrome. Results of a randomized clinical trial.
Topics: Adult; Alcoholism; Atenolol; Double-Blind Method; Female; Humans; Male; Middle Aged; Oxazepam; Progn | 1989 |
Randomized clinical trial of atenolol in patients with alcohol withdrawal.
Topics: Adult; Alcohol Withdrawal Delirium; Anti-Anxiety Agents; Anxiety; Atenolol; Benzodiazepines; Clinica | 1985 |
The role of beta blockers in alcohol withdrawal syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Double-Bli | 1988 |
Atenolol for alcohol withdrawal.
Topics: Alcohol Withdrawal Delirium; Atenolol; Benzodiazepines; Clinical Trials as Topic; Ethanol; Humans; R | 1986 |
20 other studies available for atenolol and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Sinus node dysfunction associated with discontinuation of cilostazol in a patient taking atenolol.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Cilostazol; Heart Arrest; Humans; Intraoperative Compli | 2004 |
Factors relating to the beta blocker withdrawal syndrome.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Coronary Disease; Heart Rate; Humans; Hyperthyroi | 1981 |
Withdrawal of beta-blocking drugs.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Heart Rate; Humans; Isoproterenol; Male; Middle Aged; | 1982 |
Abrupt and gradual change from clonidine to beta blockers in hypertension.
Topics: Adrenergic beta-Antagonists; Atenolol; Clonidine; Drug Interactions; Female; Humans; Hypertension; M | 1982 |
Differential effects of morphine withdrawal on cerebral beta 1- and beta 2-adrenergic receptors.
Topics: Albuterol; Animals; Atenolol; Cerebral Cortex; Dihydroalprenolol; Humans; Male; Morphine; Morphine D | 1981 |
[Withdrawal syndrome following beta blocker therapy (author's transl)].
Topics: Adult; Angina Pectoris; Atenolol; Chlorthalidone; Female; Humans; Hypertension; Middle Aged; Myocard | 1981 |
A comparison of circulatory responsiveness following the sudden withdrawal from atenolol and propranolol.
Topics: Adult; Atenolol; Blood Pressure; Catecholamines; Heart Rate; Hemodynamics; Humans; Male; Physical Ex | 1981 |
Withdrawal of long-term therapy with atenolol in hypertensive patients.
Topics: Adult; Atenolol; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Kinetics; Male; Middle Ag | 1981 |
Role of beta-adrenoceptors in the expression of morphine withdrawal signs.
Topics: Adrenergic Agents; Adrenergic beta-Antagonists; Animals; Atenolol; Behavior, Animal; Benzylamines; I | 1994 |
Beta-adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats.
Topics: Adrenergic beta-Antagonists; Animals; Anxiety; Atenolol; Cocaine; Injections, Intraperitoneal; Male; | 1993 |
Beta-adrenergic antagonists attenuate somatic and aversive signs of opiate withdrawal.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Avoidance Learning; Male; Naloxone; Narcotics; Propr | 1993 |
Organic anxiety syndrome after withdrawal of atenolol.
Topics: Aged; Anxiety Disorders; Atenolol; Diltiazem; Humans; Hypertension; Lorazepam; Male; Substance Withd | 1994 |
Beta-blocker withdrawal syndrome?
Topics: Atenolol; Humans; Male; Metoprolol; Propanolamines; Propranolol; Substance Withdrawal Syndrome | 1979 |
Adrenergic hypersensitivity after beta-blocker withdrawal in hypertrophic cardiomyopathy.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Cardiomyopathy, Hypertrophic; Coronary Disease; Drug Hyperse | 1991 |
The acute withdrawal of diltiazem and atenolol: a possible challenge to affective stability.
Topics: Adult; Angina Pectoris; Atenolol; Atrial Flutter; Bipolar Disorder; Diltiazem; Female; Humans; Hyper | 1989 |
Abrupt withdrawal of atenolol in patients with severe angina: comparison with the effects of treatment.
Topics: Angina Pectoris; Atenolol; Humans; Substance Withdrawal Syndrome | 1986 |
Abrupt withdrawal of atenolol in patients with severe angina: comparison with the effects of treatment.
Topics: Angina Pectoris; Atenolol; Coronary Disease; Humans; Substance Withdrawal Syndrome | 1986 |
Abrupt withdrawal of atenolol in patients with severe angina. Comparison with the effects of treatment.
Topics: Adult; Angina Pectoris; Atenolol; Catecholamines; Female; Heart Rate; Humans; Male; Middle Aged; Nor | 1985 |
The alcohol withdrawal syndrome.
Topics: Atenolol; Ethanol; Humans; Substance Withdrawal Syndrome | 1985 |
Regimen for the control of blood pressure and symptoms during clonidine withdrawal.
Topics: Adult; Aged; Atenolol; Blood Pressure; Chlordiazepoxide; Clonidine; Female; Heart Rate; Humans; Hype | 1985 |